Latest News
-
BEDFORD, Mass. – Stoke Therapeutics, Inc, a new company working to increase gene expression to treat a wide array of diseases caused by genetic insufficiency, announced that it has completed a $40 million Series A financing to support the further advancement of multiple pre-clinical development programs. The Series A round...
Videos
Rare disease spotlight
Only 1 week left to nominate someone for the SCAY Awards and giveaway!
There are individuals within the #sicklecell community who work tirelessly for the cause, but their work goes unnoticed. We're celebrating them!
Nominate: http://sc101.link/nominate
#sicklecell101 #scayawards
Read this inspiring article on how PhD student Katherine Gulliver’s personal experience of Williams Syndrome, influenced her further educational and professional paths. We are lucky to have Katherine as part of our Regional contacts team for Devon and Somerset. https://twitter.com/PlymUni/status/1265272895845986310
Our BA Education degree isn't just for future teachers.
Find out how the course inspired PhD student Kat Gulliver to study inclusive education abroad, and how her knowledge has supported her charity work with @HCPT and @WSF_UK
Find out more 👇
https://www.plymouth.ac.uk/courses/undergraduate/ba-education/katherine-gulliver
